Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May 17;15(5):1520.
doi: 10.3390/pharmaceutics15051520.

Formulation Strategies of Nanosuspensions for Various Administration Routes

Affiliations
Review

Formulation Strategies of Nanosuspensions for Various Administration Routes

Sıla Gülbağ Pınar et al. Pharmaceutics. .

Abstract

Nanosuspensions (NSs), which are nanosized colloidal particle systems, have recently become one of the most interesting substances in nanopharmaceuticals. NSs have high commercial potential because they provide the enhanced solubility and dissolution of low-water-soluble drugs by means of their small particle sizes and large surface areas. In addition, they can alter the pharmacokinetics of the drug and, thus, improve its efficacy and safety. These advantages can be used to enhance the bioavailability of poorly soluble drugs in oral, dermal, parenteral, pulmonary, ocular, or nasal routes for systemic or local effects. Although NSs often consist mainly of pure drugs in aqueous media, they can also contain stabilizers, organic solvents, surfactants, co-surfactants, cryoprotectants, osmogents, and other components. The selection of stabilizer types, such as surfactants or/and polymers, and their ratio are the most critical factors in NS formulations. NSs can be prepared both with top-down methods (wet milling, dry milling, high-pressure homogenization, and co-grinding) and with bottom-up methods (anti-solvent precipitation, liquid emulsion, and sono-precipitation) by research laboratories and pharmaceutical professionals. Nowadays, techniques combining these two technologies are also frequently encountered. NSs can be presented to patients in liquid dosage forms, or post-production processes (freeze drying, spray drying, or spray freezing) can also be applied to transform the liquid state into the solid state for the preparation of different dosage forms such as powders, pellets, tablets, capsules, films, or gels. Thus, in the development of NS formulations, the components/amounts, preparation methods, process parameters/levels, administration routes, and dosage forms must be defined. Moreover, those factors that are the most effective for the intended use should be determined and optimized. This review discusses the effect of the formulation and process parameters on the properties of NSs and highlights the recent advances, novel strategies, and practical considerations relevant to the application of NSs to various administration routes.

Keywords: administration routes; dosage forms; formulation strategies; nanosuspensions; production methods.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Nanosuspension preparation methods (conventional and combination technologies).
Figure 2
Figure 2
Schematic representation of the critical parameters of bottom-up technology by the fishbone diagram.
Figure 3
Figure 3
Schematic representation of the critical parameters of the high-pressure homogenization method by the fishbone diagram.
Figure 4
Figure 4
Schematic representation of the critical parameters of the wet milling method by the fishbone diagram.
Figure 5
Figure 5
Schematic representation of the nanosuspension preparation methods.

References

    1. Guner G., Yilmaz D., Yao H.F., Clancy D.J., Bilgili E. Predicting the temperature evolution during nanomilling of drug suspensions via a semi-theoretical lumped parameter model. Pharmaceutics. 2022;14:2840. doi: 10.3390/pharmaceutics14122840. - DOI - PMC - PubMed
    1. Merisko-Liversidge E.M., Liversidge G.G. Drug nanoparticles: Formulating poorly water-soluble compounds. Toxicol. Pathol. 2008;36:43–48. doi: 10.1177/0192623307310946. - DOI - PubMed
    1. Uhlemann J., Diedam H., Hoheisel W., Schikarski T., Peukert W. Modeling and simulation of process technology for nanoparticulate drug formulations—A particle technology perspective. Pharmaceutics. 2021;13:22. doi: 10.3390/pharmaceutics13010022. - DOI - PMC - PubMed
    1. Nsairat H., Khater D., Sayed U., Odeh F., Bawab A.A., Alshaer W. Liposomes: Structure, composition, types, and clinical applications. Heliyon. 2022;8:e09394. doi: 10.1016/j.heliyon.2022.e09394. - DOI - PMC - PubMed
    1. Piscatelli J.A., Ban J., Lucas A.T., Zamboni W.C. Complex factors and challenges that affect the pharmacology, safety and efficacy of nanocarrier drug delivery systems. Pharmaceutics. 2021;13:114. doi: 10.3390/pharmaceutics13010114. - DOI - PMC - PubMed

LinkOut - more resources